Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar
The Danish company's diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injection Wegovy.
Source link
The Danish company's diabetes and obesity division performed particularly well, bolstered by interest in its blockbuster injection Wegovy.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/N6K3JAGGNVCFNDPKSEQS67ZJP4.JPG "Japan looks to accept more foreigners in key policy shift")